Results 281 to 290 of about 262,716 (337)

The Association Between Breast Arterial Calcification and Subsequent Coronary Artery Calcification: A Systematic Review. [PDF]

Cureus
Nagy S, Rodriguez C, Gurreri A, Daniel K, Mihos CG, Kesselman MM.   +5 more
europepmc   +1 more source

Outcomes of percutaneous coronary intervention on saphenous vein graft and native coronary vessels.

, 2011
Mohammad Alidoosti, Seyed Kianoosh Hosseini, Ahmad Sharafi, Ebrahim Nematipour, Mojtaba Salarifar, Hamidreza Poorhoseini, Seyed Ebrahim Kassaian, Ali Mohammad Haji Zeinali, Alireza Amirzadegan, Mohammad Sadeghian, Masoumeh Lotfi-Tokalday   +10 more
openalex   +1 more source

Deep phenotyping of heart failure with preserved ejection fraction through multi‐omics integration

European Journal of Heart Failure, EarlyView.
Deep phenotyping of of heart failure with preserved ejection fraction (HFpEF) through multi‐omics integration. AI, artificial intelligence. Aims Heart failure with preserved ejection fraction (HFpEF) has become the predominant form of heart failure and a leading cause of global cardiovascular morbidity and mortality.
Jakob Versnjak, Titus Kuehne, Pauline Fahjen, Nina Jovanovic, Ulrike Löber, Gabriele G. Schiattarella, Nicola Wilck, Holger Gerhardt, Dominik N. Müller, Frank Edelmann, Philipp Mertins, Roland Eils, Michael Gotthardt, Sofia K. Forslund, Benjamin Wild, Marcus Kelm   +15 more
wiley   +1 more source

Design Optimization and Mechanical Performance Evaluation of a Modified Coronary IV-OCT Catheter Adapted for Intracranial Navigation: A Preclinical Study. [PDF]

Biosensors (Basel)
Nairuz T, Hwang YS, Kwon MY, Kim JH, Kwon SM, Yoon HJ, Hur SH, Chung J, Kim WJ, An SH, Kim JS, Lee JH, Kim CH.   +12 more
europepmc   +1 more source

Incidence of major cardiovascular events in patients with metabolic dysfunction‐associated steatotic liver disease in the general population

European Journal of Heart Failure, EarlyView.
Aims Major adverse cardiovascular events (MACE) related to cardiovascular disease are a major cause of death in patients with metabolic dysfunction‐associated steatotic liver disease (MASLD). We explored the impact of MASLD on incident MACE and overall mortality in the general population in Germany.
Yvonne Huber, Lea Hofmann, Jürgen H. Prochaska, Thomas Koeck, Julian Chalabi, Norbert Pfeiffer, Manfred Beutel, Konstantin Strauch, Karl J. Lackner, Oliver Tüscher, Thomas Münzel, Matthias M. Weber, Julia Weinmann‐Menke, Philipp Wild, Peter R. Galle, Jörn M. Schattenberg   +15 more
wiley   +1 more source

Spider-Like Coronary Anatomy; the True Spider!

Arquivos Brasileiros de Cardiologia
Levent Cerit, Hamza Duygu, Kamil Gülşen, Hatice Kemal, Barcin Ozcem   +4 more
doaj   +1 more source

The Pullback Pressure Gradient: Transforming Invasive Coronary Physiology from Lesion Assessment to Disease Pattern Characterization-A Perspective. [PDF]

Medicina (Kaunas)
Dziewierz A, Zdzierak B, Bartuś S, Zasada W.   +3 more
europepmc   +1 more source

Late‐onset epilepsy of unknown etiology is more treatment‐responsive than acquired lesional late‐onset epilepsy

Epilepsia Open, EarlyView.
Abstract Objective Late‐onset epilepsy of unknown etiology (LOEU) carries an elevated risk of dementia, suggesting that it may represent an early manifestation of neurodegenerative or cerebrovascular disease. Direct comparisons between LOEU and acquired lesional late‐onset epilepsy (LOE) may elucidate clinical features specific to LOEU.
L. Brian Hickman, Bhavya Pandey, Alexander Fish, Mohit Bandla, Adnan Husein, Corinne Allas, Harika Kottakota, Lauren Herzog, Keith Vossel, John M. Stern   +9 more
wiley   +1 more source

Coronary artery stenosis, plaque burden, and severity of myocardial ischemia. [PDF]

Eur Heart J Imaging Methods Pract
Kero T, Knuuti J, Bär S, Bax JJ, Saraste A, Maaniitty T.   +5 more
europepmc   +1 more source

Late‐onset unexplained epilepsy as a risk factor for cognitive impairment and dementia: Protocol for a multi‐center prospective longitudinal observational study (ELUCID)

Epilepsia Open, EarlyView.
Abstract Objective Late‐onset unexplained epilepsy (LoUE), defined as epilepsy onset after age 55 without an obvious cause, is an important risk factor for dementia. Studies have shown that 10%–25% of individuals with LoUE develop dementia within 3–4 years following their first seizure.
Alice D. Lam, Emily L. Johnson, Rani A. Sarkis, Leah J. Blank, Tyler E. Gaston, Mouhsin M. Shafi, Rodrigo Zepeda, Kyle R. Pellerin, Nathalie Jette, Douglas N. Greve, Lori B. Chibnik, Rebecca E. Amariglio, Gad A. Marshall, M. Brandon Westover   +13 more
wiley   +1 more source